Table 1:
Medically Significant Candida spp.
Table 2: Characteristics of the Major Candida
spp.
Table 3: Susceptibility of Candida
spp. to Antifungal Agents
Table 4: Interpretive Breakpoints for
Antifungal Susceptibility Testing
Table 5. Summary of Key Points for Selection of
Therapy
Table 6: Therapy for Vaginal Candidiasis: Topical
Agents
Table 7: Therapies of Choice for Invasive
Candidiasisa
Vignettes
Logan McCool:
The Discovery and Naming of Candida
Simi Vincent:
Origin of the
Names of Species of Candida
Review
Article: Singh N, Treatment of opportunistic mycoses: how
long is long enough? Lancet Infect Dis 2003;3:703-08
Review Article: Schaudin C,
Stoodley P, Kainovic' A, O'Keeffe T, Costerton B, Robinson D, Baum M, Ehrlich
G, Webster P. Bacterial Biofilms, Other Structures Seen as Mainstream
Concepts. Microbe 2007;2:231-237.
Review Article:
Adhikari P, Mietzner T. Cell Mediated Immunity. 2008.
Review Article:
Efflux Pumps as a Mechanism
of Antimicrobial Resistance. 2008
Review Article: Raad, I., Hanna, H. and
Maki, D. Intravascular Catheter-related Infections: Advances in Diagnosis,
Prevention and Management. The LANCET Infectious Diseases 2007; Vol.7, Issue 10,
645-657.
Guidelines: Pappas PG, et al.
Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by
the Infectious Diseases Society of America. Clin Infect Dis
2009;48:503-535.
Betts RF, Nucci M, et al.
A Multicenter, Double-Blind Trial of a High-Dose
Caspofungin Treatment Regimen versus a standard Caspofungin Treatment
Regimen for Adult Patients with Invasive Candidiasis. Clin Inf
Dis. 2009;48:1676-84.
Golnaz J, Zuravleff J.
Retinitis and Endophthalmitis.
2007.
Gram stain, 2008
Hamza et al.
Single-Dose Fluconazole versus Standard Therapy for
Oropharyngeal Candidiasis in HIV-Infected Patients: A Randomized,
Double-Blind, Double-Dummy Trial. Clin Infect Dis. 2008 Nov
15;47(10):1270-6.
Harrington A.
Differentiation of Candida albicans from non-albicans
yeast directly from blood cultures by Gram stain morphology.
Eur J Clin Microbiol Infect Dis 2007;26:325-329.
Legrand F, et al.
Adjuvant corticosteroid therapy for chronic
disseminated candidiasis. Clin Infect Dis. 2008;46:696-702.
Pappas PG, et al.
Micafungin versus caspofungin for treatment of
candidemia and other forms of invasive candidiasis. Clin
Infect Dis 2007;45:883-893.
Reboli A, Rotstein C, Pappas P, Schranz J, Krause D, Walsh T, Anidulafungin
Study Group.
Anidulafungin versus fluconazole for invasive
candidiasis.
N Engl J Med 2007;357(13):1347.
Ruan SY,
Lee LN,
et al.
Candida glabrata fungaemia in intensive care units.
Clin Microbiol Infect 2007 Nov 28 [Epub ahead of print]Sun RL, et al.
Clinical characteristics and outcome of Candida
keratitis. Am J Ophthalmol 2007;143:1043-1045.
Van Hal et al. Candida dubliniensis Meningitis as Delayed Sequela of Treated
C. dubliniensis Fungemia.
Emerg Infect Dis.
2008 February;
14(2):
327–329.
Zaoutis T. et
al.
A Prospective, Multicenter Study of Caspofungin for
the Treatment of Documented Candida or Aspergillus Infections in Pediatric
Patients. PEDIATRICS. 2009 Mar;123(3):877-84.
Colombo AL, et al.
Caspofungin Use in Patients with Invasive Candidiasis
caused by Common Non-albicans Candida Species: Review of the Caspofungin
Database. Antimicrob Agents Chemother 2010;Mar 15 [Epub
ahead of print]
Authors
John H. Rex, M.D.,
Jack D. Sobel, M.D.,
William Powderly, M.D.